Given the expression of smooth muscle actin in the tumor cells, we entertained the possibility of a cutaneous myoid/myogenic sarcoma with aberrant cytokeratin expression, but additional myogenic markers including smooth muscle heavy chain myosin (SMMS), H‐caldesmon, desmin, and myogenin were negative, significantly diminishing that diagnostic consideration. The gene discussed is MYOG; the disease is neoplasm.